innovation in cll the practicalities and potential of finite therapy with btki platforms
Published 1 month ago • 126 plays • Length 1:12:47
Download video MP4
Download video MP3
Similar videos
-
1:14:36
defying the odds with innovation in cll
-
1:06:45
real-world challenges and solutions with btki in cll: therapeutic insights for community practice
-
48:43
taking the next steps with next-generation btki in cll, mcl, and dlbcl
-
2:00:33
fine-tuning the wave of innovation in cll
-
2:00:15
achieving innovation in cll: targeted options and next steps in disease management
-
1:25:33
customizing care in cll with btk inhibitors
-
1:02:27
personalized treatment with emerging btk inhibitor options in cll/sll and mcl
-
1:36:57
mapping the new era in cll management with precision medicine
-
1:29:05
btk inhibitors in cll: evidence-informed therapy selection, safety, and sequential care
-
1:36:53
new standards for cll care with btk inhibitors
-
1:29:53
the winning way with btk inhibitors in cll
-
1:29:34
pushing boundaries in cll: targeted therapy, novel combinations, and precision medicine
-
53:10
exploring newer time-limited btki combinations in cll
-
32:51
part 2 - how do i use btki for cll management? - dr. nitin jain, usa
-
1:13:17
cll care with btk inhibitors: selection, safety, and sequencing across the disease continuum
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
1:27:57
new rules for btk inhibitors in cll
-
2:32
challenges with implementing cars in cll and the promise of allogeneic products
-
3:27
catherine coombs, md, on challenges with btki in cll treatment
Clip.africa.com - Privacy-policy